The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Open accessAbstract
Glioblastomas are lethal cancers characterized by florid angiogenesis promoted in part by glioma stem cells (GSCs). Because hypoxia regulates angiogenesis, we examined hypoxic responses in GSCs. We now demonstrate that hypoxia-inducible factor HIF2alpha and multiple HIF-regulated genes are preferentially expressed in GSCs in comparison to non-stem tumor cells and normal neural progenitors. In tumor specimens, HIF2alpha colocalizes with cancer stem cell markers. Targeting HIFs in GSCs inhibits self-renewal, proliferation, and survival in vitro, and attenuates tumor initiation potential of GSCs in vivo. Analysis of a molecular database reveals that HIF2A expression correlates with poor glioma patient survival. Our results demonstrate that GSCs differentially respond to hypoxia with distinct HIF induction patterns, and HIF2alpha might represent a promising target for antiglioblastoma therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since HIF-2α is strongly expressed in the cytoplasm of NB tumor cells at physiological oxygen levels (5% O2), this could suggest additional largely unexplored functions of HIF-2α in the cytoplasm, independent of HIF-1β-dependent transcription, such as regulation of mRNA translation [9,43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In NB clinical specimens, HIF-1α expression negatively correlates with the presence of blood vessels indicating that HIF-1α is expressed exclusively in hypoxic cells [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, HIF-2α is located in dense clusters of cells adjacent to blood vessels, referred to as the perivascular niche, which have a neural crest-like phenotype, and are HIF-1α negative, suggesting they are not hypoxic [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, treatment with PT2385 had no effect on tumor growth, did not impact transcription of HIF target genes and did not modulate chemotherapy response [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis69,70”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [70]
In the citing paper
“Hypoxia was first shown to induce the CSC phenotype in glioma [77] and, subsequently, in breast cancer [78, 79], in a HIF-dependent manner.”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
Self-citationHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., Vitis, S. D., Fiocco, R., Foroni, C., DiMeco, F., & Vescovi, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D. K., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,844
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M. D., Geschwind, D. H., Bronner-Fraser, M. E., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,842
Cited by
Sorted by citations
Items 801–900 of 1,000
GPR133 Promotes Glioblastoma Growth in Hypoxia
Frenster, J. D., Inocencio, J. F., Xu, Z., Dhaliwal, J., Alghamdi, A., Zagzag, D., Bayin, N. S., & Placantonakis, D. G. (2017) · Neurosurgery · doi:10.1093/neuros/nyx227 · Cited by 21
Li, F., Tang, C., Jin, D., Guan, L., Wu, Y., Liu, X., Wu, X., Wu, Q., & Gao, D. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4009 · Cited by 21
Self-citationThe hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & LLeonart, M. E. (2015) · Inside the Cell · doi:10.1002/icl3.1039 · Cited by 23
Ng, C. X., Lee, S. Y., Yap, X. Y., Wong, Y. H., Loh, J. S., Ang, K. P., Lee, W. H., Xu, W., Yong, P. V. C., & Lee, S. H. (2025) · Discover Oncology · doi:10.1007/s12672-025-04085-8 · Cited by 20
Multimodal Role of PACAP in Glioblastoma
D’Amico, A. G., Maugeri, G., Vanella, L., Pittalà, V., Reglődi, D., & D’Agata, V. (2021) · Brain Sciences · doi:10.3390/brainsci11080994 · Cited by 20
Novel read‐through fusion transcript Bcl2l2‐Pabpn1 in glioblastoma cells
Zhang, L., Wang, D., Han, X. W., Guo, X., Cao, Y., Xia, Y., & Gao, D. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17481 · Cited by 20
Self-citationHu, N., Zou, L., Wang, C., & Song, G. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03074-w · Cited by 20
Buccarelli, M., Castellani, G., & Ricci‐Vitiani, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101625 · Cited by 20
Gimple, R. C., Zhang, G., Wang, S., Huang, T., Lee, J., Taori, S., Lv, D., Dixit, D., Halbert, M. E., Morton, A. R., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.158077 · Cited by 20
Self-citationLiu, H., Xu, S., Yong, T., Wei, Z., Bie, N., Zhang, X., Li, X., Li, J., Li, S., Wang, S., et al. (2023) · Advanced Materials · doi:10.1002/adma.202211980 · Cited by 21
Signals that regulate the oncogenic fate of neural stem cells and progenitors
Swartling, F. J., Bolin, S., Phillips, J. J., & Persson, A. I. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.027 · Cited by 22
A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells
Jalota, A., Kumar, M., Das, B. C., Yadav, A. K., Chosdol, K., & Sinha, S. (2018) · Oncotarget · doi:10.18632/oncotarget.24839 · Cited by 20
Kumar, S., Visvanathan, A., Arivazhagan, A., Santhosh, V., Somasundaram, K., & Umapathy, S. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02879 · Cited by 20
Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance
Deheeger, M., Lesniak, M. S., & Ahmed, A. U. (2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.295 · Cited by 19
Kumar, N., Mondal, M., Arathi, B. P., Sundaresan, N. R., & Somasundaram, K. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194900 · Cited by 19
Iriondo, O., Mecenas, D., Li, Y., Chin, C. R., Thomas, A., Moriarty, A., Marker, R., Wang, Y. J., Hendrick, H., Amzaleg, Y., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2028 · Cited by 20
Tiezzi, D. G., Valejo, F. A. M., Marana, H. R. C., Carrara, H. H. A., Benevides, L., Antônio, H. M. R., Sicchieri, R. D., Milanezi, C. M., Silva, J. S., & de Andrade, J. M. (2011) · Medical Oncology · doi:10.1007/s12032-011-0014-x · Cited by 19
Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy
Takao, S., Ding, Q., & Matsubara, S. (2012) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-012-0547-1 · Cited by 19
Cancer stem cells and autophagy: Facts and Perspectives
Hamaï, A., Codogno, P., & Mehrpour, M. (2014) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2014.2e1005 · Cited by 20
High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells
Sun, J. C., He, F., Yi, W., Wan, M., Li, R., Wei, X., Wu, R., & Niu, D.-L. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.22.37 · Cited by 19
Voigt, A., Nowick, K., & Almaas, E. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005739 · Cited by 19
Nanoparticles for Stem Cell Therapy Bioengineering in Glioma
Ruiz-Garcia, H. J., Alvarado-Estrada, K., Krishnan, S., Quiñones‐Hinojosa, A., & Trifiletti, D. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.558375 · Cited by 20
Integration and Visualization of Regulatory Elements and Variations of the EPAS1 Gene in Human
Kristan, A., Debeljak, N., & Kunej, T. (2021) · Genes · doi:10.3390/genes12111793 · Cited by 23
Adult Neurogenesis and Glial Oncogenesis: When the Process Fails
Batista, C. M., Mariano, E. D., Barbosa, B. J. A. P., Morgalla, M. H., Marie, S. K. N., Teixeira, M. J., & Lepski, G. A. (2014) · BioMed Research International · doi:10.1155/2014/438639 · Cited by 19
Stem cells: a model for screening, discovery and development of drugs
Kitambi, S. S., & Chandrasekar, G. (2011) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s16417 · Cited by 19
Inhibitory Activities of Trichostatin A in U87 Glioblastoma Cells and Tumorsphere-Derived Cells
Sassi, F. D. A., Caesar, L., Jaeger, M. D. C., Nör, C., Abujamra, A. L., Schwartsmann, G., de Farias, C. B., Brunetto, A. L., Lopez, P. L. D. C., & Roesler, R. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0241-7 · Cited by 20
Minhas, G., Mathur, D., Balakrishnan, R., Sharma, N. K., Paanu, V., & Anand, A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00386 · Cited by 20
Spatial heterogeneity in glioblastoma: Decoding the role of perfusion
Saha, S., Bhat, A., Kukal, S., Phalak, M., & Kumar, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189383 · Cited by 18
Spatial enrichment of cellular states in glioblastoma
Eberhart, C. G., & Bar, E. E. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02165-3 · Cited by 18
Endocannabinoid signaling in glioma
Costas‐Insua, C., & Guzmán, M. (2022) · Glia · doi:10.1002/glia.24173 · Cited by 19
Inukai, M., Yokoi, A., Ishizuka, Y., Hashimura, M., Matsumoto, T., Oguri, Y., Nakagawa, M., Ishibashi, Y., Ito, T., Kumabe, T., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00848-w · Cited by 18
Sloan, A. R., Lee-Poturalski, C., Hoffman, H., Harris, P. L. R., Elder, T. E., Richardson, B., Kerstetter-Fogle, A. E., Cioffi, G., Schröer, J., Desai, A., et al. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac172 · Cited by 18
Self-citationGliomas: a reflection of temporal gliogenic principles
Sojka, C., & Sloan, S. A. (2024) · Communications Biology · doi:10.1038/s42003-024-05833-2 · Cited by 18
Stem Cells in Brain Tumor Development
Llaguno, S. R. A., Chen, Y., McKay, R. M., & Parada, L. F. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00002-4 · Cited by 18
Stereotactic Body Radiation Therapy in Non–Small-Cell Lung Cancer
Chi, A., Tomé, W. A., Fowler, J., Komaki, R. U., Nguyen, N. P., Mehta, M. P., & Welsh, J. S. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181df4b3f · Cited by 18
The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas
Duetzmann, S., Gessler, F. A., Harter, P. N., Gerlach, R., Mittelbronn, M. G. A., Seifert, V., & Kögel, D. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.4.12660 · Cited by 18
Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells
Olin, M. R., Andersen, B. M., Litterman, A. J., Grogan, P. T., Sarver, A. L., Robertson, P. T., Liang, X., Chen, W., Parney, I. F., Hunt, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1166 · Cited by 18
ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
Schabort, J. J., Nam, A.-R., Lee, K.-H., Kim, S. W., Lee, J. E., & Cho, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228697 · Cited by 18
Radin, D. P., Smith, G. T., Moushiaveshi, V., Wolf, A., Bases, R. E., & Tsirka, S. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852940 · Cited by 18
Expert opinion on translational research for advanced glioblastoma treatment
Cui, X., Wang, Y., Zhou, J., Wang, Q., & Kang, C. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0012 · Cited by 18
A microRNA Link to Glioblastoma Heterogeneity
Singh, S. K., Vartanian, A., Burrell, K. E., & Zadeh, G. M. (2012) · Cancers · doi:10.3390/cancers4030846 · Cited by 19
Koga, H., Tsedensodnom, O., Tomimaru, Y., Walker, E. J., Lee, H. C., Kim, K. M., Yano, H., Wands, J. R., & Kim, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039981 · Cited by 18
HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy
Kwak, J., Lee, N.-H., Lee, H., Hong, I., & Nam, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9846 · Cited by 18
Metabolic Alterations at the Crossroad of Aging and Oncogenesis
Raffaghello, L., & Longo, V. D. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.003 · Cited by 19
Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review
Guo, S., Zheng, S., Liu, M., & Wang, G. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081024 · Cited by 18
Tiezzi, D. G., Clagnan, W. S., Mandarano, L. R. M., de Sousa, C. B., Marana, H. R. C., Tiezzi, M. G., & de Andrade, J. M. (2013) · Clinics · doi:10.6061/clinics/2013(05)03 · Cited by 17
Lu, C.-S., Hsieh, J.-L., Lin, C.-Y., Tsai, H.-W., Su, B.-H., Shieh, G.-S., Su, Y.-C., Lee, C.-H., Chang, M.-Y., Wu, C., et al. (2015) · Gene Therapy · doi:10.1038/gt.2014.122 · Cited by 17
Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids
Rosenberg, T., Thomassen, M., Jensen, S. S., Larsen, M. J., Sørensen, K., Hermansen, S. K., Kruse, T. A., & Kristensen, B. W. (2015) · CNS Oncology · doi:10.2217/cns.14.48 · Cited by 17
Galán‐Cobo, A., Sánchez-Silva, R., Serna‐Gallego, A., Abreu‐Rodríguez, I., Muñoz-Cabello, A. M., & Echevarría, M. (2013) · Gene · doi:10.1016/j.gene.2013.03.075 · Cited by 17
Novel therapies hijack the blood–brain barrier to eradicate glioblastoma cancer stem cells
Vengoji, R., Ponnusamy, M. P., Rachagani, S., Mahapatra, S., Batra, S. K., Shonka, N., & Macha, M. A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy171 · Cited by 17
Shen, S., Yan, Z., Wu, J., Liu, X., Guan, G., Zou, C., Guo, Q., Zhu, C., Liu, T., Chen, C., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581197 · Cited by 17
The implications of nitric oxide metabolism in the treatment of glial tumors
Mazurek, M., & Rola, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105172 · Cited by 17
Chargari, C., Moncharmont, C., Lévy, A., Guy, J., Bertrand, G., Guilbert, M., Rousseau, C., Védrine, L., Alphonse, G., Toillon, R., et al. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2012.1666 · Cited by 17
Transcriptional landscape of bone marrow-derived very small embryonic-like stem cells during hypoxia
Gharib, S. A., Khalyfa, A., Kucia, M., Dayyat, E. A., Kim, J., Clair, H. B., & Gozal, D. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-63 · Cited by 17
Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma
Gaelzer, M. M., dos Santos, M. S., Coelho, B. P., de Quadros, A. H., Simão, F., Usach, V., Guma, F. T. C. R., Setton-Avruj, C. P., Lenz, G., & Salbego, C. G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0126-6 · Cited by 17
Câmara, D. A. D., Mambelli, L. I., Porcacchia, A. S., & Kerkis, I. (2016) · Journal of Cancer · doi:10.7150/jca.16629 · Cited by 17
Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma
Yu, W., Liang, S., & Zhang, C. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8507-9 · Cited by 17
The top cited articles on glioma stem cells in Web of Science.
Yi, F., Ma, J., Ni, W., Chang, R., Liu, W., Han, X., Pan, D., Liu, X., & Jian-wu, Q. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.15.011 · Cited by 17
Wang, P., Gong, S., Liao, B., Liu, J., Zhao, L., & Wu, N. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03823-w · Cited by 16
Hypoxia-induced one-carbon metabolic reprogramming in glioma stem-like cells
He, X., Wang, J., Shi, M.-Y., Liu, C., & Teng, Z. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad048 · Cited by 16
Wei, Y., Geng, S., Si, Y., Yang, Y., Chen, Q., Huang, S., Chen, X., Xu, W., Liu, Y., & Jiang, J. (2023) · Advanced Science · doi:10.1002/advs.202306715 · Cited by 16
Inferring Tumor Proliferative Organization from Phylogenetic Tree Measures in a Computational Model
Scott, J. G., Maini, P. K., Anderson, A. R. A., & Fletcher, A. G. (2019) · Systematic Biology · doi:10.1093/sysbio/syz070 · Cited by 16
Muftuoglu, Y., & Pajonk, F. (2021) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2021.01.002 · Cited by 16
Wang, P., Gong, S., Pan, J., Wang, J., Zou, D., Xiong, S., Zhao, L., Yan, Q., Deng, Y., Wu, N., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00486-0 · Cited by 16
Targeting Orphan G Protein-Coupled Receptor 17 with T0 Ligand Impairs Glioblastoma Growth
Doan, P., Nguyen, P., Murugesan, A., Subramanian, K., Saravanan, K. M., Vignesh, K., Abraham, B. G., Stringer, B. W., Kadalmani, B., Yli-Harja, O. P., et al. (2021) · Cancers · doi:10.3390/cancers13153773 · Cited by 16
UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation
Wang, Y., Liu, X., Wang, M., Wang, Y., Wang, S., Jin, L., Liu, M., Zhou, J. Y., & Chen, Y. (2023) · Oncogene · doi:10.1038/s41388-023-02842-z · Cited by 16
Molecular Mechanisms of Tumor Angiogenesis
Burrell, K. E., & Zadeh, G. M. (2012) · InTech eBooks · doi:10.5772/27264 · Cited by 16
Targeting glioma stem cells via the Hedgehog signaling pathway
Jiang, C., Chen, L., Cui, Y., Du, W., Li, Y., Liu, Y., Liu, X., & Piao, X. (2014) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.139715 · Cited by 16
Tumor Initiation in Human Malignant Melanoma and Potential Cancer Therapies
Ma, J., & Frank, M. H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010790909254 · Cited by 16
Danish, F., Qureshi, M. A., Mirza, T., Amin, W., Sufiyan, S., Naeem, S., Arshad, F., & Mughal, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010572 · Cited by 16
Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
Chen, H., Nikolić, A., Singhal, D., & Gallo, M. (2022) · Cancers · doi:10.3390/cancers14194942 · Cited by 16
Ishikawa, T., Ogura, Y., Tanaka, K., Nagashima, H., Sasayama, T., Endo, M., & Minami, Y. (2022) · Cancer Science · doi:10.1111/cas.15630 · Cited by 15
Yazdani, B., Sirous, H., Enguita, F. J., Brogi, S., Wing, P. A. C., & Fassihi, A. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10650-6 · Cited by 16
A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles
Cao, L., Han, R., Zhao, Y., Qin, X., Li, Q., Xiong, H., Kong, Y., Liu, Z., Li, Z., Dong, F., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114032 · Cited by 15
Self-citationLee, B. W. L., Chuah, Y. H., Yoon, J., Grinchuk, O. V., Liang, Y., Hirpara, J. L., Shen, Y., Wang, L. C., Lim, Y. T., Zhao, T., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06718-2 · Cited by 15
Agosti, E., Zeppieri, M., Ghidoni, M., Ius, T., Tel, A., Fontanella, M. M., & Panciani, P. P. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i5.604 · Cited by 15
Application of hydrogels for targeting cancer stem cells in cancer treatment
Li, F., Li, Z., Wei, C., Xu, L., Liang, Y., Yan, J., Li, Y., He, B., & Sun, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117486 · Cited by 18
Self-citationSpatiotemporal modeling reveals high-resolution invasion states in glioblastoma
Manoharan, V. T., Abdelkareem, A. O., Gill, G., Brown, S. M., Gillmor, A. H., Hall, C., Seo, H., Narta, K., Grewal, S., Dang, N. H., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03407-3 · Cited by 15
Haroon, M., & Kang, S. C. (2025) · Applied Biological Chemistry · doi:10.1186/s13765-025-00992-0 · Cited by 15
VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis
Seagroves, T. N., Peacock, D. L., Liao, D., Schwab, L. P., Krueger, R. L., Handorf, C. R., Haase, V. H., & Johnson, R. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090310 · Cited by 15
Cherry, T., Longo, S. L., Tovar-Spinoza, Z. S., & Post, D. E. (2010) · Gene Therapy · doi:10.1038/gt.2010.100 · Cited by 15
Walter, S. G., Scheidt, S., Nißler, R., Gaisendrees, C., Zarghooni, K., & Schildberg, F. A. (2021) · Cancers · doi:10.3390/cancers13061466 · Cited by 16
Petterson, S. A., Sørensen, M. D., Burton, M., Thomassen, M., Kruse, T. A., Michaelsen, S. R., & Kristensen, B. W. (2022) · Brain Pathology · doi:10.1111/bpa.13111 · Cited by 15
Oncolytic adenoviruses: A thorny path to glioma cure
Ulasov, I. V., Borovjagin, A. V., Schroeder, B., & Baryshnikov, A. Y. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.009 · Cited by 15
Biological and clinical implications of cancer stem cells in primary brain tumors
Maugeri‐Saccà, M., Martino, S. D., & Maria, R. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00006 · Cited by 15
Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm
López-Bertoni, H., Li, Y.-Q., & Laterra, J. (2015) · Biology and Medicine · doi:10.4172/0974-8369.1000s2-001 · Cited by 15
Implications of Oxygen Homeostasis for Tumor Biology and Treatment
Garvalov, B. K., & Acker, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_12 · Cited by 17
Hamidian, A., Vaapil, M., von Stedingk, K., Fujita, T., Persson, C., Eriksson, P., Veerla, S., Preter, K. D., Speleman, F., Fujii, H., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.150 · Cited by 15
OCT4B mediates hypoxia-induced cancer dissemination
Lin, S.-C., Chung, C.-H., Chung, C.-H., Kuo, M.-H., Hsieh, C.-H., Chiu, Y.-F., Shieh, Y., Chou, Y., & Wu, C.-W. (2018) · Oncogene · doi:10.1038/s41388-018-0487-6 · Cited by 15
Radiation Therapy for Glioma Stem Cells
Rizzo, A. E., & Yu, J. S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16537-0_6 · Cited by 15
Melanoma‐initiating cells: a compass needed
Refaeli, Y., Bhoumik, A., Roop, D. R., & Ronai, Z. (2009) · EMBO Reports · doi:10.1038/embor.2009.184 · Cited by 16
Amorntaveechai, A., Osathanon, T., Pavasant, P., & Sooampon, S. (2022) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2022.03.003 · Cited by 14
Murnan, K., Horbinski, C., & Stegh, A. H. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0262 · Cited by 15
Carroll, C., Manaprasertsak, A., Castro, A. B., van den Bos, H., Spierings, D. C. J., Wardenaar, R., Bukkuri, A., Engström, N., Baratchart, E., Yang, M., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0396 · Cited by 14
The Brain Protein Atlas: A conglomerate of proteomics datasets of human neural tissue
Lam, K. H. B., Faust, K., Yin, R., Fiala, C., & Diamandis, P. (2022) · PROTEOMICS · doi:10.1002/pmic.202200127 · Cited by 15
Sloan, A. E., Nock, C. J., Ye, X., Buerki, R., Chang, S. M., Lesser, G. J., Norden, A. D., Cloughesy, T. F., Olson, J. J., Kerstetter-Fogle, A. E., et al. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04193-3 · Cited by 14
Self-citationThe role of octamer binding transcription factors in glioblastoma multiforme
Rooj, A. K., Bronisz, A., & Godlewski, J. A. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.003 · Cited by 15
Mikheev, A. M., Ramakrishna, R. R., Stoll, E. A., Mikheeva, S. A., Beyer, R. P., Plotnik, D. A., Schwartz, J. L., Rockhill, J. K., Silber, J. R., Born, D. E., et al. (2012) · Aging Cell · doi:10.1111/acel.12004 · Cited by 14
HIF-miR-215-KDM1B promotes glioma-initiating cell adaptation to hypoxia
Hu, J. Y., & Wang, X. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1181877 · Cited by 14
Novel approaches to target cancer initiating cells–Eliminating the root of the cancer
McCubrey, J. A., Abrams, S. L., Umezawa, K., Cocco, L., Martelli, A. M., Franklin, R. A., Chappell, W. H., & Steelman, L. S. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.011 · Cited by 13
Metadata
- Authors
- Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N.
- Affiliations
- Duke Medical Center (US)
- Cleveland Clinic (US)
- Corresponding author
- Rich, Jeremy N.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 15
- Issue
- 6
- Pages
- 501-513
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2693960
- OpenAlex
- W2039075677
- Cited by
- 1,354
- References
- 65
- Citations by year
- 2026: 41 · 2025: 40 · 2024: 49 · 2023: 72 · 2022: 92 · 2021: 98 · 2020: 72 · 2019: 75 · 2018: 74 · 2017: 93 · 2016: 97 · 2015: 97 · 2014: 96 · 2013: 80 · 2012: 101
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 116659, R01CA116659, CA112958, R01CA129958)
- National Institute of Neurological Disorders and Stroke (K02NS047409, R01NS054276, NS054276, NS047409)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- HIF-2α, glioma stem cells, glioblastoma, hypoxia, angiogenesis, self-renewal, tumor initiation, cancer stem cell markers, patient survival, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Brain Neoplasms, Cell Survival, Cells, Cultured, Glioblastoma, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Stem Cells, Biomarkers, Tumor, Neoplastic Stem Cells, Cell Hypoxia, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
